Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tarek Hassaan Mouhieddine, M.D.

Co-Author

This page shows the publications co-authored by Tarek Mouhieddine and Mark Bustoros.
Connection Strength

0.818
  1. Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant. Nat Commun. 2020 06 12; 11(1):2996.
    View in: PubMed
    Score: 0.236
  2. Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression. J Clin Oncol. 2020 07 20; 38(21):2380-2389.
    View in: PubMed
    Score: 0.235
  3. Established and Novel Prognostic Biomarkers in Multiple Myeloma. Am Soc Clin Oncol Educ Book. 2017; 37:548-560.
    View in: PubMed
    Score: 0.186
  4. Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma. Nat Cancer. 2020 May; 1(5):493-506.
    View in: PubMed
    Score: 0.058
  5. Advancements in Nanomedicine for Multiple Myeloma. Trends Mol Med. 2018 06; 24(6):560-574.
    View in: PubMed
    Score: 0.051
  6. Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression. J Clin Invest. 2018 06 01; 128(6):2487-2499.
    View in: PubMed
    Score: 0.051
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.